Thomas M. Hooton

35.6k total citations · 14 hit papers
187 papers, 25.1k citations indexed

About

Thomas M. Hooton is a scholar working on Epidemiology, Urology and Rheumatology. According to data from OpenAlex, Thomas M. Hooton has authored 187 papers receiving a total of 25.1k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Epidemiology, 57 papers in Urology and 39 papers in Rheumatology. Recurrent topics in Thomas M. Hooton's work include Urinary Tract Infections Management (100 papers), Urinary Bladder and Prostate Research (54 papers) and Pelvic floor disorders treatments (36 papers). Thomas M. Hooton is often cited by papers focused on Urinary Tract Infections Management (100 papers), Urinary Bladder and Prostate Research (54 papers) and Pelvic floor disorders treatments (36 papers). Thomas M. Hooton collaborates with scholars based in United States, Canada and Germany. Thomas M. Hooton's co-authors include Walter E. Stamm, Lindsay E. Nicolle, Kalpana Gupta, Richard Colgan, Anthony J. Schaeffer, Ann E. Stapleton, Pacita L. Roberts, Robert W. Haley, David H. Culver and T.Grace Emori and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Thomas M. Hooton

184 papers receiving 23.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

2006 2.5k citations Thomas M. Hooton et al. Clinical Infectious Diseases profile →
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

2011 2.1k citations Kalpana Gupta, Thomas M. Hooton et al. Clinical Infectious Diseases profile →
THE EFFICACY OF INFECTION SURVEILLANCE AND CONTROL PROGRAMS IN PREVENTING NOSOCOMIAL INFECTIONS IN US HOSPITALS

1985 1.5k citations Thomas M. Hooton et al. profile →
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America

2010 1.4k citations Thomas M. Hooton, Suzanne Bradley et al. Clinical Infectious Diseases profile →
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults

2005 1.1k citations Lindsay E. Nicolle, Suzanne Bradley et al. Clinical Infectious Diseases profile →
Management of Urinary Tract Infections in Adults

1993 629 citations Walter E. Stamm, Thomas M. Hooton et al. New England Journal of Medicine profile →
IDENTIFYING PATIENTS AT HIGH RISK OF SURGICAL WOUND INFECTION

1985 579 citations Thomas M. Hooton et al. profile →
DIAGNOSIS AND TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION

1997 550 citations Thomas M. Hooton, Walter E. Stamm profile →
Uncomplicated Urinary Tract Infection

2012 533 citations Thomas M. Hooton New England Journal of Medicine profile →
Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa

2019 503 citations Lindsay E. Nicolle, Kalpana Gupta et al. Clinical Infectious Diseases profile →
Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection

2007 460 citations David A. Rosen, Thomas M. Hooton et al. PLoS Medicine profile →
Nosocomial infections in U.S. hospitals, 1975–1976

1981 373 citations Thomas M. Hooton et al. profile →
Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America

2018 284 citations Lindsay E. Nicolle, Kalpana Gupta et al. Clinical Infectious Diseases profile →
Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials

2024 44 citations Florian Wagenlehner, Caroline Perry et al. profile →

Peers

Countries citing papers authored by Thomas M. Hooton

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Hooton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Hooton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Hooton more than expected).

Fields of papers citing papers by Thomas M. Hooton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Hooton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Hooton. The network helps show where Thomas M. Hooton may publish in the future.

Co-authorship network of co-authors of Thomas M. Hooton

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Hooton. A scholar is included among the top collaborators of Thomas M. Hooton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Hooton. Thomas M. Hooton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P31 Efficacy and safety of oral gepotidacin in the treatment of uncomplicated urinary tract infection: results of two randomized, multicentre Phase 3 trials (EAGLE-2 and EAGLE-3) 2023 ·JAC-Antimicrobial Resistance ·Florian Wagenlehner, Caroline Perry, Thomas M. Hooton, Nicole E. Scangarella-Oman, Helen Millns, Hwa-ping Feng, Marcy Powell, (unknown), (unknown), Amanda Sheets, (unknown), John Breton, (unknown)	2
2	2832. Gepotidacin Efficacy in E. coli Drug-Resistant Phenotypes: A Pooled Analysis of the EAGLE-2 and EAGLE-3 Randomized Controlled Trials in Uncomplicated Urinary Tract Infection 2023 ·Open Forum Infectious Diseases ·Thomas M. Hooton, Caroline Perry, (unknown), Amanda Sheets, (unknown), Helen Millns, (unknown), Nicole E. Scangarella-Oman, (unknown)	1
3	Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America breakdown → 2018 ·Clinical Infectious Diseases ·Lindsay E. Nicolle, Kalpana Gupta, Suzanne Bradley, Richard Colgan, Gregory P. DeMuri, Dimitri Drekonja, Linda O. Eckert, Suzanne E. Geerlings, Béla Köves, Thomas M. Hooton, Manisha Juthani‐Mehta, Shandra L. Knight, Sanjay Saint, Anthony J. Schaeffer, Barbara W. Trautner, Björn Wullt, Reed Siemieniuk	284
4	Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections 2017 ·Science Translational Medicine ·Henry L. Schreiber, Matt S. Conover, Wen‐Chi Chou, Michael E. Hibbing, Abigail L. Manson, Karen Dodson, Thomas J. Hannan, Pacita L. Roberts, Ann E. Stapleton, Thomas M. Hooton, Jonathan Livny, Ashlee M. Earl, Scott J. Hultgren	109
5	POSTER ABSTRACTS 2014 ·Open Forum Infectious Diseases ·Lilian M. Abbo, Aida E. Casiano-Colón, (unknown), Thomas M. Hooton, (unknown), (unknown)	1
6	Quantitative Metabolomics Reveals an Epigenetic Blueprint for Iron Acquisition in Uropathogenic Escherichia coli 2009 ·PLoS Pathogens ·Jeffrey P. Henderson, Jan R. Crowley, Jerome S. Pinkner, Jennifer N. Walker, Pablo Tsukayama, Walter E. Stamm, Thomas M. Hooton, Scott J. Hultgren	176
7	Genetic Variation of the Human Urinary Tract Innate Immune Response and Asymptomatic Bacteriuria in Women 2009 ·PLoS ONE ·Thomas R. Hawn, Delia Scholes, Hongwei Wang, (unknown), Ann E. Stapleton, Marta Janer, Alan Aderem, Walter E. Stamm, Lue Ping Zhao, Thomas M. Hooton	58
8	Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection breakdown → 2007 ·PLoS Medicine ·David A. Rosen, Thomas M. Hooton, Walter E. Stamm, Peter A. Humphrey, Scott J. Hultgren	460
9	Brief Report: Randomized Controlled Trial of Zinc Supplementation for Persistent Diarrhea in Adults With HIV-1 Infection 2006 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), Thomas M. Hooton, Noel S. Weiss, Robert H. Gilman, Mark H. Wener, (unknown), (unknown), Juan Echevarría, (unknown), King K. Holmes	32
10	Acute Uncomplicated Cystitis in an Era of Increasing Antibiotic Resistance: A Proposed Approach to Empirical Therapy 2004 ·Clinical Infectious Diseases ·Thomas M. Hooton, Rachel Besser, Betsy Foxman, Thomas R. Fritsche, L. E. Nicolle	148
11	Virulence characteristics of Escherichia coli causing asymptomatic bacteriuria 1997 ·Clinical Infectious Diseases ·Kalpana Gupta, Ann E. Stapleton, Thomas M. Hooton, C. L. Fennell, Mansour Samadpour, Walter E. Stamm	3
12	Pelvic anatomy and recurrent UTI in young women 1997 ·Clinical Infectious Diseases ·Thomas M. Hooton, Ann E. Stapleton, C. Winter, Pacita L. Roberts, D. Scholes, Tamara Bavendam, Walter E. Stamm	5
13	A prospective study of asymptomatic bacteriuria in young sexually active women 1997 ·Clinical Infectious Diseases ·Thomas M. Hooton, D. Scholes, Ann E. Stapleton, C. Winter, Pacita L. Roberts, Kalpana Gupta, Walter E. Stamm	2
14	Bacterial infections in adult patients hospitalized with AIDS: case-control study of prophylactic efficacy of trimethoprim-sulfamethoxazole versus aerosolized pentamidine 1997 ·International Journal of STD & AIDS ·Stephen R. Tabet, Melissa Krone, Thomas M. Hooton, Laura A. Koutsky, King K. Holmes	7
15	A Prospective Study of Risk Factors for Symptomatic Urinary Tract Infection in Young Women 1996 ·New England Journal of Medicine ·Thomas M. Hooton, (unknown), James P. Hughes, (unknown), (unknown), Ann E. Stapleton, Andy Stergachis, (unknown)	438
16	Evolution of Rifampin Resistance in Human Immunodeficiency Virus-Associated Tuberculosis 1995 ·American Journal of Respiratory and Critical Care Medicine ·Charles M. Nolan, Diana L. Williams, M. Donald Cave, K. D. Eisenach, Hiyam H. El-Hajj, Thomas M. Hooton, Richard Thompson, Stefan Goldberg	47
17	Association of urogenital infections with spermicides 1993 ·Thomas M. Hooton, S J Klebanoff	1
18	An Outbreak of Respiratory Syncytial Virus in a Bone Marrow Transplant Center 1992 ·The Journal of Infectious Diseases ·Robert Harrington, Thomas M. Hooton, Robert C. Hackman, Gregory A. Storch, Barbara M. Osborne, Curt A. Gleaves, Ann Benson, Joel D. Meyers	266
19	Protecting ourselves and our patients from nosocomial infections 1989 ·Respiratory Care ·Thomas M. Hooton	3
20	Urinary Tract Infections: From Pathogenesis to Treatment 1989 ·The Journal of Infectious Diseases ·Walter E. Stamm, Thomas M. Hooton, James R. Johnson, Carolyn Johnson, Ann E. Stapleton, Pacita L. Roberts, S L Moseley, Stephan D. Fihn	126

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact